SpectraCure Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for SpectraCure.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth37.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans

Jul 31
SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That SpectraCure (STO:SPEC) Will Use Its Cash Wisely

Feb 23
We're Hopeful That SpectraCure (STO:SPEC) Will Use Its Cash Wisely

We're Not Very Worried About SpectraCure's (STO:SPEC) Cash Burn Rate

Nov 09
We're Not Very Worried About SpectraCure's (STO:SPEC) Cash Burn Rate

Companies Like SpectraCure (STO:SPEC) Are In A Position To Invest In Growth

Jul 27
Companies Like SpectraCure (STO:SPEC) Are In A Position To Invest In Growth

Companies Like SpectraCure (STO:SPEC) Are In A Position To Invest In Growth

Mar 09
Companies Like SpectraCure (STO:SPEC) Are In A Position To Invest In Growth

SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans

Nov 08
SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans

SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans

Jul 26
SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans

We Think SpectraCure (STO:SPEC) Can Afford To Drive Business Growth

Mar 19
We Think SpectraCure (STO:SPEC) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About SpectraCure's (STO:SPEC) Cash Burn Situation

Nov 16
Here's Why We're Not Too Worried About SpectraCure's (STO:SPEC) Cash Burn Situation

We Think SpectraCure (STO:SPEC) Can Easily Afford To Drive Business Growth

Aug 03
We Think SpectraCure (STO:SPEC) Can Easily Afford To Drive Business Growth

We're Not Worried About SpectraCure's (STO:SPEC) Cash Burn

Apr 16
We're Not Worried About SpectraCure's (STO:SPEC) Cash Burn

Companies Like SpectraCure (STO:SPEC) Can Afford To Invest In Growth

Jan 01
Companies Like SpectraCure (STO:SPEC) Can Afford To Invest In Growth

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SpectraCure has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

OM:SPEC - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20240-23-33-18N/A
6/30/20240-21-32-18N/A
3/31/2024-2-21-32-18N/A
12/31/20230-20-34-19N/A
9/30/20231-23-36-21N/A
6/30/20231-23-37-22N/A
3/31/20238-24-37-22N/A
12/31/20221-25-33-23N/A
9/30/2022N/A-25-32-23N/A
6/30/2022N/A-25-29-20N/A
3/31/2022N/A-25-30-23N/A
12/31/2021N/A-23-27-19N/A
9/30/20211-22-22-13N/A
6/30/20211-19-25-16N/A
3/31/20211-16-21-10N/A
12/31/20201-15-20-9N/A
9/30/20201-15-26-14N/A
6/30/20201-15-15-12N/A
3/31/20201-15-25-10N/A
12/31/20191-14-25-10N/A
9/30/20191-16-32-13N/A
12/31/20181-13-24-12N/A
9/30/20181-9-15-8N/A
12/31/20173-9N/A6N/A
9/30/20173-8N/A-6N/A
6/30/20173-7N/A-7N/A
3/31/20173-7N/A-7N/A
12/31/20163-6N/A-20N/A
9/30/20163-7N/A-8N/A
6/30/20162-7N/A-2N/A
3/31/20162-7N/AN/AN/A
12/31/20151-6N/A-10N/A
9/30/20151-6N/AN/AN/A
6/30/20151-6N/AN/AN/A
3/31/20151-4N/AN/AN/A
12/31/20141-4N/A-1N/A
12/31/20131-6N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if SPEC's forecast earnings growth is above the savings rate (1.2%).

Earnings vs Market: Insufficient data to determine if SPEC's earnings are forecast to grow faster than the Swedish market

High Growth Earnings: Insufficient data to determine if SPEC's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if SPEC's revenue is forecast to grow faster than the Swedish market.

High Growth Revenue: Insufficient data to determine if SPEC's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SPEC's Return on Equity is forecast to be high in 3 years time


Discover growth companies